ONCOGENEX PHARMACEUTICALS INC | 10,275 Euro | +0,001 +0,01 % | |
| WKN: A0Q8G8 ISIN: US68230A1060 Ticker-Symbol: SP4A | Frankfurt | 28.05.12 | 08:05 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 03.05. | ONCOGENEX PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | - | SEC Filings | |
| 03.05. | OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development Highlights for First Quarter of 2012 | 25 | PR Newswire | |
| Conference call to be held on Thursday, May 3, 2012 at 4:30 p.m. Eastern
Time
BOTHELL, WA, and VANCOUVER, May 3, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced... Mehr lesen zu: OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development Highlights for First Quarter of 2012 | ||||
| 26.04. | 2012 Economic Outlook - Report Highlights OncoGenex Pharmaceuticals Inc and Pacira Pharmaceuticals Inc | 6 | MarketWire | |
| HONG KONG -- (Marketwire) -- 04/26/12 -- Today, www.BrightonMarkets.com announced new reports highlighting OncoGenex Pharmaceuticals Inc (NASDAQ: OGXI) and Pacira Pharmaceuticals Inc (NASDAQ: PCRX).... Mehr lesen zu: 2012 Economic Outlook - Report Highlights OncoGenex Pharmaceuticals Inc and Pacira Pharmaceuticals Inc | ||||
| 25.04. | OncoGenex to Webcast Discussion of First Quarter 2012 Financial Results on Thursday, May 3, 2012 | 14 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, April 25, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's
first quarter 2012 financial results will be released... Mehr lesen zu: OncoGenex to Webcast Discussion of First Quarter 2012 Financial Results on Thursday, May 3, 2012 | ||||
| 27.03. | OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences | 23 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, BC, March 27, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that senior
management will provide a corporate presentation at the following
... Mehr lesen zu: OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences | ||||
| 23.03. | OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters | 17 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, March 23, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the
underwriters of its previously announced public offering of common
... Mehr lesen zu: OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters | ||||
| 16.03. | OncoGenex Pharma beschließt Kapitalerhöhung | 107 | BörseGo | |
| Seattle (BoerseGo.de) - Der Medizinentwickler OncoGenex Pharmaceuticals mit Sitz in Seattle (US-Bundesstaat Washington) hat eine Kapitalerhöhung beschlossen. Es soll neue Aktien im Umfang von 4,165... Mehr lesen zu: OncoGenex Pharma beschließt Kapitalerhöhung | ||||
| 16.03. | OncoGenex Pharma Prices 4.16 Mln Shares At $12/shr | 42 | AFX News | |
| WASHINGTON (dpa-AFX) - OncoGenex Pharmaceuticals Inc. (OGXI) said it has
priced an underwritten public offering of 4.16 million shares at a purchase
price of $12.00 per share. Net proceeds... Mehr lesen zu: OncoGenex Pharma Prices 4.16 Mln Shares At $12/shr | ||||
| 16.03. | OncoGenex (OGXI) Prices 4.17M Offering at $12/Share | - | StreetInsider.com | |
| 16.03. | OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering | 40 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, March 16, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that it has priced
an underwritten public offering of 4,165,000 shares of... Mehr lesen zu: OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering | ||||
| 15.03. | OncoGenex Pharma Launches Stock Offering | 64 | AFX News | |
| WASHINGTON (dpa-AFX) - OncoGenex Pharmaceuticals, Inc. (OGXI) said Thursday
that it commenced a public offering of its common stock. The company expects to grant the underwriters a 30-day... Mehr lesen zu: OncoGenex Pharma Launches Stock Offering | ||||
| 15.03. | OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock | 22 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, March 15, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that it commenced
a public offering of its common stock. OncoGenex expects... Mehr lesen zu: OncoGenex Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock | ||||
| 08.03. | OncoGenex Q4 Loss Widens; Provides Update On Custirsen Development Program | 85 | AFX News | |
| PETAH TIKVA (dpa-AFX) - OncoGenex Pharmaceuticals, Inc. (OGXI) reported that
its fourth-quarter net loss widened to $9.6 million, or $0.98 per share, from
$2.8 million, or $0.31 per share... Mehr lesen zu: OncoGenex Q4 Loss Widens; Provides Update On Custirsen Development Program | ||||
| 08.03. | Teva Pharma (TEvA0, OncoGenex (OGXI) Update Custirsen Phase III | 6 | StreetInsider.com | |
| 08.03. | Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer | 66 | Business Wire | |
| Second Phase 3 Trial Evaluating Survival Benefit of Custirsen Planned
to Initiate in 2012
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and OncoGenex... Mehr lesen zu: Teva and OncoGenex Announce Updates to Custirsen Development Program in Advanced Prostate Cancer | ||||
| 08.03. | OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2011 and Provides Update on Clinical Development Program | 23 | PR Newswire | |
| BOTHELL, Wash. and VANCOUVER, British Columbia, March 8, 2012 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced its fourth quarter and year end 2011 financial results... Mehr lesen zu: OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2011 and Provides Update on Clinical Development Program | ||||
| 28.02. | OncoGenex to Webcast Discussion of Fourth Quarter 2011 Financial Results on Thursday, March 8, 2012 | 21 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, British Columbia, Feb. 28, 2012 /PRNewswire/ -
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the
Company's fourth quarter 2011 financial results... Mehr lesen zu: OncoGenex to Webcast Discussion of Fourth Quarter 2011 Financial Results on Thursday, March 8, 2012 | ||||
| 27.02. | OncoGenex Announces Data Highlighting OGX-427 at 27th Annual European Association of Urology Congress | 5 | PR Newswire | |
| BOTHELL, Wash. and VANCOUVER, Feb. 27, 2012 /PRNewswire/ --OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that preclinical data utilizing their pipeline compound OGX-427 was presented... Mehr lesen zu: OncoGenex Announces Data Highlighting OGX-427 at 27th Annual European Association of Urology Congress | ||||
| 07.02. | OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences | 8 | PR Newswire | |
| BOTHELL, WA and VANCOUVER, BC, Feb. 7, 2012 /PRNewswire/ - OncoGenex
Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott
Cormack, Chief Executive Officer, will provide a corporate presentation
... Mehr lesen zu: OncoGenex Pharmaceuticals to Present at Upcoming Investor Conferences | ||||
| 20.01. | Up Next For OncoGenex Pharma... | 59 | AFX News | |
| WASHINGTON (dpa-AFX) - Cancer is the second most common cause of death in
the U.S., exceeded only by heart disease, accounting for nearly 1 of every 4
deaths, according to the American Cancer... Mehr lesen zu: Up Next For OncoGenex Pharma... | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
